IMAC Holdings, Inc. (BACK)
OTCMKTS · Delayed Price · Currency is USD
0.0750
+0.0050 (7.14%)
Oct 5, 2025, 8:00 PM EDT
IMAC Holdings Market Cap
IMAC Holdings has a market cap or net worth of $283.87 thousand as of October 7, 2025. Its market cap has decreased by -88.05% in one year.
Market Cap
283.87K
Enterprise Value
2.17M
Revenue
57.80K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since February 13, 2019, IMAC Holdings's market cap has decreased from 26.65M to 283.87K, a decrease of -98.93%. That is a compound annual growth rate of -49.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 283.87K | -88.90% |
| Dec 31, 2024 | 2.56M | 1.63% |
| Dec 29, 2023 | 2.52M | -61.20% |
| Dec 30, 2022 | 6.48M | -78.30% |
| Dec 31, 2021 | 29.88M | 64.93% |
| Dec 31, 2020 | 18.12M | 41.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |